from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1858/modB

LFCtreatmentdescriptionclass of inhibitor

0.653

Amikacinug/mL Amikacintranslation

0.874

Cap5-10ug/mL Capreomycintranslation

2.552

Rox10-50 ug/mL Roxithromycintranslation

-0.088

SM2-5 ug/mL Streptomycintranslation

2.178

Tet5-10 ug/mL Tetracyclinetranslation

0.118

Rif0.2-5ug/mL Rifampicintranscription

-0.504

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.132

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.071

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.513

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.187

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.339

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.038

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.869

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.342

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.481

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.073

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.913

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.298

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.241

KCN5-20 ug/mL Potassium cyaniderespiration

0.193

NaN30.2-2 mM Sodium aziderespiration

-0.201

Nigericin50 uM Nigericinrespiration

0.266

TRC10-150 ug/mL Triclosanrespiration

0.590

TRZ10-25 ug/mL Thioridazinerespiration

0.999

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.311

menadione6-10 ug/mL Menadionerespiration

0.729

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.297

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.065

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.194

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.354

NRP_1Non-replicating persistence stage 1dosRassociated

-0.795

Amp0.2mg/mL AmpicillincellWall

-0.403

Cephalexin20-100 ug/mL CephalexincellWall

0.003

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.749

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.407

EMB10-20 ug/mL EthambutolcellWall

-0.214

Eta12-40 ug/mL EthionamidecellWall

-0.509

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.301

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.342

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.027

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.625

BZA0.12 mg/mL BenzamidearomaticAmides

-0.464

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.417

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.331

H2O24 mM hydrogen peroxideDNAdamaging

0.088

Levo10 ug/mL LevofloxacinDNAdamaging

-0.348

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.057

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.308

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.069

UVUV-irradiationDNAdamaging

0.780

ARP41-4 ug/mL Antitubercular compound ARP4?

0.445

Antimycin12.5-50 ug/mL Antimycin A?

-0.095

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.573

PA_110-50 ug/mL Antitubercular compound PA-1?

0.623

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.493

PA8240.2-2 ug/mL PA-824?

-0.513

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.296

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.068

Verapamil50 uM Verapamil?

-0.053

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.291

methoxatin10-20 ug/mL Methoxatin?